Response-oriented preemptive therapy against cytomegalovirus disease with low-dose ganciclovir: a prospective evaluation.
about
Safety and efficacy of low-dose methotrexate for pediatric patients with steroid-refractory acute graft-versus-host disease after hematopoietic stem cell transplantation.Occurrence of adverse events caused by valganciclovir as pre-emptive therapy for cytomegalovirus infection after allogeneic stem cell transplantation is reduced by low-dose administration.Endoscopic diagnosis of cytomegalovirus gastritis after allogeneic hematopoietic stem cell transplantation.Evaluation of the validity of preemptive therapy against cytomegalovirus disease based on antigenemia assay with a cutoff of 20 positive cells per two slides.Chryseobacterium indologenes, a possible emergent organism resistant to carbapenem antimicrobials after stem cell transplantation.In vivo T-cell depletion with alemtuzumab in allogeneic hematopoietic stem cell transplantation: Combined results of two studies on aplastic anemia and HLA-mismatched haploidentical transplantation.The clinical role of procalcitonin in hematopoietic SCT.Preemptive therapy with ganciclovir 5 mg/kg once daily for cytomegalovirus infection after unrelated cord blood transplantation.Low-dose acyclovir prophylaxis for the prevention of herpes simplex virus disease after allogeneic hematopoietic stem cell transplantation.Endoscopic evaluation for cytomegalovirus enterocolitis after allogeneic haematopoietic stem cell transplantation.The effect of different ATG preparations on immune recovery after allogeneic hematopoietic stem cell transplantation for severe aplastic anemia.A randomized controlled trial of plasma real-time PCR and antigenemia assay for monitoring CMV infection after unrelated BMT.Cytomegalovirus antigenemia and outcome of patients treated with pre-emptive ganciclovir: retrospective analysis of 241 consecutive patients undergoing allogeneic hematopoietic stem cell transplantation.Late hemorrhagic cystitis after reduced-intensity hematopoietic stem cell transplantation (RIST).Reduced-intensity stem cell transplantation from an HLA-identical sibling donor in patients with myeloid malignancies.Regimen-related toxicity following reduced-intensity stem-cell transplantation (RIST): comparison between Seattle criteria and National Cancer Center Common Toxicity Criteria (NCI-CTC) version 2.0.High-grade cytomegalovirus antigenemia after hematopoietic stem cell transplantation.L-index as a novel index to evaluate both the intensity and duration of lymphopenia after allogeneic hematopoietic stem cell transplantation.Evaluation of cytomegalovirus-specific T-cell reconstitution in patients after various allogeneic haematopoietic stem cell transplantation using interferon-gamma-enzyme-linked immunospot and human leucocyte antigen tetramer assays with an immunodomi
P2860
Q33411063-8FA01594-377E-4783-A712-FABFF10188ECQ33425731-5C289C2B-008A-4A87-A92B-F51B2D926FFEQ33920594-0C484AFF-7578-4316-A088-06CE2A99EF01Q34989242-E3576E02-8D31-48AD-89E3-485801286499Q37577800-EC61B40C-C959-4782-930E-7CAA7C52CF9EQ39459351-57CDF767-DD2D-4989-90FE-E51171065D2CQ40295927-BEDA5E0D-203A-4372-848B-CC436CEEE4D4Q40435345-3495B008-5FA2-4D8C-8811-52349674D4FEQ42280732-7AB10BC2-A560-47F5-B9A5-CF8A23B8CC22Q42844651-CCC895F7-E458-4F78-AFDA-93F2A7259CE0Q43014781-7167A84F-3D84-4A1B-9113-39B17B4F14CEQ43228476-2F441B37-43B9-48FB-8A95-64E13E365B9DQ44603444-9DCD1F27-EEBF-411E-BCCD-E8AB7A00748CQ44661110-261CD8A1-C07F-494B-8037-794943AF22C5Q44817216-22E2BDDB-DB78-47A4-9E5A-007941E769E2Q44885917-DDFDFAEB-C459-49B4-9951-E73185B8A91FQ46693835-EC4E7A4C-D1A3-4C51-8CB3-967994C6273BQ51348958-D698D0C6-4042-466E-AC71-ABFE77C0D6BDQ53649676-78301C3B-4C1F-41CC-AB39-D51D392AAFE2
P2860
Response-oriented preemptive therapy against cytomegalovirus disease with low-dose ganciclovir: a prospective evaluation.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Response-oriented preemptive t ...... vir: a prospective evaluation.
@en
Response-oriented preemptive t ...... vir: a prospective evaluation.
@nl
type
label
Response-oriented preemptive t ...... vir: a prospective evaluation.
@en
Response-oriented preemptive t ...... vir: a prospective evaluation.
@nl
prefLabel
Response-oriented preemptive t ...... vir: a prospective evaluation.
@en
Response-oriented preemptive t ...... vir: a prospective evaluation.
@nl
P2093
P1433
P1476
Response-oriented preemptive t ...... vir: a prospective evaluation.
@en
P2093
Aki Chizuka
Akiko Saito
Atsushi Makimoto
Hideo Kunitoh
Hironari Niiya
Hiroshi Matsubara
Kensei Tobinai
Kunihisa Nakai
Mutsuko Ohnishi
Ryuji Tanosaki
P304
P356
10.1097/00007890-200202270-00015
P577
2002-02-01T00:00:00Z